Cover Image
市場調查報告書

巴西的醫療市場未來展望

Brazil Healthcare Market Outlook 2020

出版商 RNCOS E-Services Pvt. Ltd. 商品編碼 219639
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
巴西的醫療市場未來展望 Brazil Healthcare Market Outlook 2020
出版日期: 2016年03月01日 內容資訊: 英文 105 Pages
簡介

本報告網羅巴西的醫療市場各方面,彙整目前產業趨勢,政府所實行的措施,參與企業的詳細資訊等資料。

第1章 分析師的觀點

第2章 調查方法

第3章 醫療市場概要

第4章 市場趨勢與推動因素

  • 可喜的人口統計
  • 流行病學
    • 結核
    • 高血壓
    • 肥胖症
    • 糖尿病
    • 癌症
  • 企業合併、收購 (M&A) 的醫療產業的成長加速
  • 醫療產業上IT普及率的上升

第5章 醫療產業的未來展望

  • 醫療基礎設施
    • 醫院數
    • 病床數
    • 人力資源
  • 醫藥品市場
    • 處方藥
    • 學名藥
    • 成藥
    • 進出口
  • 醫療設備產業
  • 醫療用IT市場
    • 電子醫療
    • 行動醫療
    • 遠程醫療
    • 醫療圖像、資訊系統

第6章 市場機會

  • 醫療保險產業
  • 醫療觀光產業
  • 臨床實驗產業
  • 生物科技產業

第7章 法規環境

第8章 政府的醫療計劃

第9章 競爭情形

  • 醫院服務
  • 製藥
  • 醫療設備
  • 醫療用IT

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Brazil is considered as one of the most lucrative healthcare market in Latin America, with consistent ranking amongst the top five global destinations for medical tourism. The country attracts a variety of medical tourists to take advantage of the successful and world-renowned cosmetic surgery industry. Growing demand for private healthcare has helped fuel a boom in the sector, which remains dominated by local players and has recently witnessed a number of mergers as many seek to capitalize on higher demand and consolidate their positions.

According to our report, "Brazil Healthcare Market Outlook 2020", with better standards of living, the healthcare expenditure in the country has been rising continuously which is driving the healthcare industry. Among the healthcare sectors, the pharmaceutical market in the country witnessed tremendous growth, especially Prescription drugs market that enjoyed lion's share of nearly 50% in 2015. However, the generics drug segment is forecasted to do well in future. With several factors, such as increasing patent expiries and greater generic company involvement in Brazil, the segment is anticipated to be the main factor for growth of the pharmaceutical market in the country. Besides, innovation and improvements in the medical equipment sector have been consistent in Brazil.

Healthcare spending in the country is anticipated to grow at a CAGR of around 5.8% during 2016-2020. The main factors behind the high healthcare expenditure include the prevalence of various diseases in the country, like hypertension. Other major prevalent diseases covered in the report include cancer, tuberculosis, obesity and diabetes.

As per our findings, the future outlook of Brazil healthcare IT-industry is quite optimistic as the IT segment has witnessed significant mergers and acquisition in 2015. The world's leading healthcare IT companies are also looking towards Brazil as an ideal destination for their business expansion. Brazil passed a new law allowing foreign companies to invest capital in private hospitals for the first time, a move expected to appeal to those eager to capitalize on high demand for private healthcare in the country, and bring much-needed funding to the sector. Investors from all over the globe are eager to invest in the country's healthcare sector. For instance, India based drugmaker, Lupin, has acquired Medquímica Indústria Farmacêutica, a Brazilian branded generics and OTC maker, expanding its presence in Latin America through Brazil.

Our report provides an in-depth research and analysis of the key segments, namely Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry, Healthcare IT industry, and other emerging market segments. It also highlights the current industry trends; presenting the key driver and foreign investments to enable clients understand the market structure and its prospective during the forecasted period. The report also covers detailed information about the active market players in hospital services, pharmaceutical, medical devices and healthcare IT-sector.

Table of Contents

1. Analyst View

2. Research Methodology

3. Healthcare Market Overview

4. Market Trends and Drivers

  • 4.1 Favorable Demographics
  • 4.2 Epidemiology
    • 4.2.1 Tuberculosis
    • 4.2.2 Hypertension
    • 4.2.3 Obesity
    • 4.2.4 Diabetes
    • 4.2.5 Cancer
  • 4.3 Healthcare industry accelerated by Merger and Acquisition
  • 4.4 Increased IT Penetration in Healthcare Industry

5. Healthcare Industry Outlook to 2020

  • 5.1 Healthcare Infrastructure
    • 5.1.1 Hospitals
    • 5.1.2 Beds
    • 5.1.3 Human Resource
  • 5.2 Pharmaceutical Market
    • 5.2.1 Prescription Drug
    • 5.2.2 Generic Drugs
    • 5.2.3 OTC Drugs
    • 5.2.4 Import and Export
  • 5.3 Medical Equipment Industry
  • 5.4 Healthcare IT-Market
    • 5.4.1 E-health
    • 5.4.2 M-health
    • 5.4.3 Telemedicine
    • 5.4.4 Medical Imaging Information System

6. Market Opportunities

  • 6.1 Health Insurance Industry
  • 6.2 Medical Tourism Industry
  • 6.3 Clinical Trials Industry
  • 6.4 Biotech Industry

7. Regulatory Environment

8. Government Healthcare Programs

9. Competitive Landscape

  • 9.1 Hospital Services
    • 9.1.1 Group Hospital Conceição (GHC)
    • 9.1.2 Rede D'Or Ltda.
    • 9.1.3 The Albert Einstein Israeli Hospital (HIAE)
    • 9.1.4 Universidade Federal do Maranhão (UFMA)
  • 9.2 Pharmaceuticals
    • 9.2.1 Sanofi-Aventis
    • 9.2.2 Bayer
    • 9.2.3 Novartis
    • 9.2.4 Pfizer
  • 9.3 Medical Equipment
    • 9.3.1 GE Healthcare
    • 9.3.2 Philips Healthcare
    • 9.3.3 Air Liquide
    • 9.3.4 Baxter
  • 9.4 Healthcare IT
    • 9.4.1 Agfa HealthCare
    • 9.4.2 MV Sistemas
    • 9.4.3 Wheb Sistemas SA
    • 9.4.4 TOTVS

List of Figures:

  • Figure 3-1: Healthcare Expenditure (Billion US$), 2014-2020
  • Figure 3-2: Healthcare Spending Percentage of GDP in Comparison to Latin American Countries (2013)
  • Figure 4-1: Spending on Medicines by Age Group (%), 2015
  • Figure 4-2: Share of Different Diseases in Population (2015)
  • Figure 4-3: Percentage of Population Diagnosed with Hypertension (2011, 2015 & 2018)
  • Figure 4-4: Percentage of Population with Obesity (2011, 2015 & 2018)
  • Figure 4-5: Overweight Population by Gender (%), 2015
  • Figure 4-6: Percentage of Population with Diabetes (2011, 2015 & 2018)
  • Figure 5-1: Share of Public and Private Hospitals (2014)
  • Figure 5-2: Forecast for Share of Public and Private Hospitals (2020)
  • Figure 5-3: Number of Hospital Beds ('000), 2014-2020
  • Figure 5-4: Share of Public and Private Hospital Beds (2014)
  • Figure 5-5: Number of Doctors ('000), 2014-2020
  • Figure 5-6: Number of Nurses ('000), 2014-2020
  • Figure 5-7: Share of Brazilian Pharmaceutical Market in Latin America (2015)
  • Figure 5-8: Pharmaceutical Market (Billion BRL), 2014-2020
  • Figure 5-9: Pharmaceutical Market (Billion Units), 2014-2020
  • Figure 5-10: Pharmaceutical Market by Segment (%), 2015
  • Figure 5-11: Forecast for Pharmaceutical Market by Segment (%), 2020
  • Figure 5-12: Share of Domestic and Foreign Pharmaceutical Laboratories (2015)
  • Figure 5-13: Pharmaceutical Market by Region (%), 2015
  • Figure 5-14 : Prescription Drug Market (Billion BRL), 2014-2020
  • Figure 5-15: Prescription Drug Market (Million Units), 2014-2020
  • Figure 5-16: Generic Drugs Market (Billion BRL), 2014-2020
  • Figure 5-17: Generic Drugs Market (Million Units), 2014-2020
  • Figure 5-18: OTC Drug Market (Billion US$), 2014-2020
  • Figure 5-19: OTC Drugs Market (Million Units), 2014-2020
  • Figure 5-20: Pharmaceutical Imports (Billion US$), 2010-2013
  • Figure 5-21: Pharmaceutical Exports (Billion US$), 2010-2013
  • Figure 5-22: Medical Equipment Market (Billion US$), 2014-2020
  • Figure 5-23: Medical Equipment Imports (Billion US$), 2011, 2013 & 2014
  • Figure 5-24: Medical Equipment Exports (Million US$), 2011 & 2013
  • Figure 5-25: Healthcare IT Market (Billion US$), 2014-2020
  • Figure 5-26: E-health Market (Million US$), 2014-2020
  • Figure 5-27: M-health Market (Million US$), 2014-2020
  • Figure 5-28: Telemedicine Market (Million US$), 2014-2020
  • Figure 5-29: Medical Imaging Information System Market (Million US$), 2014-2020
  • Figure 5-30: Picture Archiving and Communications Systems (PACS) Market (Million US$), 2014-2020
  • Figure 6-1: Private Health Insurance Net Premium (Billion BRL), 2011-2014
  • Figure 6-2: Number of Clinical Studies (2011-2015)

List of Tables:

  • Table 4-1: Demographic Characteristics (2010-2016)
  • Table 5-1: Number of Healthcare Institutions (2014)
  • Table 5-2: Number of Public Hospital Network Working for SUS (2014)
  • Table 5-3: Share of Hospitals by Region (2014)
  • Table 5-4: Number of Doctors per Thousand Populations by Top Cities (2013)
  • Table 5-5: Market Share of Leading Pharmaceutical Companies (2013)
  • Table 5-6: Leading Drugs by Sales (Million US$), 2013
  • Table 5-7: Market Share of Leading Generic Drugs Companies (2013)
  • Table 8-1: Key Goals under Various Parts of UPA 24-hours Program
Back to Top